Immunotherapy approaches for the treatment of diffuse midline gliomas

JD Bernstock, SE Hoffman, AD Kappel… - …, 2022 - Taylor & Francis
Diffuse midline gliomas (DMG) are a highly aggressive and universally fatal subgroup of
pediatric tumors responsible for the majority of childhood brain tumor deaths. Median overall …

[HTML][HTML] Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas

A Noon, S Galban - Neoplasia, 2023 - Elsevier
Diffuse midline glioma (DMG) is the leading cause of brain tumor-related deaths in children.
DMG typically presents with variable neurologic symptoms between ages 3 and 10 …

Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies

M Markouli, D Strepkos, C Piperi - International journal of molecular …, 2022 - mdpi.com
Hematologic malignancies are a large and heterogeneous group of neoplasms
characterized by complex pathogenetic mechanisms. The abnormal regulation of epigenetic …

Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening …

X Qiao, X Wu, S Chen, MM Niu, H Hua… - Journal of Enzyme …, 2024 - Taylor & Francis
Colorectal cancer (CRC) is one of the most common cancers worldwide. Nowadays, owing
to the complex mechanism of tumorigenesis, simultaneous inhibition of multiple targets is an …

[HTML][HTML] Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma

LM Arms, RJ Duchatel, ER Jackson… - Journal of Controlled …, 2024 - Elsevier
Diffuse midline glioma (DMG), including tumors diagnosed in the brainstem (diffuse intrinsic
pontine glioma-DIPG), is the primary cause of brain tumor-related death in pediatric patients …

Diffuse Intrinsic Pontine Glioma (DIPG): A Review of Current and Emerging Treatment Strategies.

LJ Weisbrod, A Thiraviyam, R Vengoji, N Shonka… - Cancer Letters, 2024 - Elsevier
Diffuse intrinsic pontine glioma (DIPG) is a childhood malignancy of the brainstem with a
dismal prognosis. Despite recent advances in its understanding at the molecular level, the …

Impact of chromatin dynamics and DNA repair on genomic stability and treatment resistance in pediatric high-grade gliomas

L Pinto, H Baidarjad, N Entz-Werlé, E Van Dyck - Cancers, 2021 - mdpi.com
Simple Summary Pediatric high-grade gliomas (pHGGs) are the leading cause of mortality in
pediatric neuro-oncology, due in great part to treatment resistance driven by complex DNA …

[HTML][HTML] H2A. Z histone variants facilitate HDACi-dependent removal of H3. 3K27M mutant protein in pediatric high-grade glioma cells

KB Leszczynska, A Freitas-Huhtamäki, C Jayaprakash… - Cell reports, 2024 - cell.com
Diffuse intrinsic pontine gliomas (DIPGs) are deadly pediatric brain tumors, non-resectable
due to brainstem localization and diffusive growth. Over 80% of DIPGs harbor a mutation in …

Advances in Treatment of Diffuse Midline Gliomas

C Cacciotti, KD Wright - Current Neurology and Neuroscience Reports, 2023 - Springer
Abstract Purpose of Review Diffuse midline gliomas (DMGs) generally carry a poor
prognosis, occur during childhood, and involve midline structures of the central nervous …

New progress in the treatment of diffuse midline glioma with H3K27 M alteration

Z Yang, L Sun, H Chen, C Sun, L Xia - Heliyon, 2024 - cell.com
Diffuse midline glioma with H3K27 M alteration is a primary malignant tumor located along
the linear structure of the brain, predominantly manifesting in children and adolescents. The …